This question concerns many patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or liraglutide (Victoza, Saxenda) for type 2 diabetes or weight management
Emerging evidence suggests that ALC levels are reduced in individuals with MDD, and this deficiency may contribute to depressive symptoms through disruptions in mitochondrial fatty acid transport, neuroplasticity, and neurotransmission
To sum up, intestinal microbiota can effectively regulate the process of HT by increasing intestinal permeability, molecular simulation, bystander activation, epitope spreading, activation of inflammatory bodies, autophagy defects, trace elements absorption, thyroid hormone metabolism, and so on
The AI is being used in the discovery and design of next-generation GLP-1 analogs